Osteoporosis International

, Volume 16, Issue 2, pp 134–141 | Cite as

Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark

Original Article

Abstract

Aim: To compare the number of patients diagnosed with osteoporosis and osteoporotic fractures in Denmark, with the number of subjects expected to have osteoporosis. Subjects and methods: From the National Hospital Discharge Register, records for all patients diagnosed with osteoporosis and/or with osteoporotic fractures between 1995 and 1999 were retrieved. Based on normal Danish values for BMD, the expected number of subjects aged 50 years or more with osteoporosis according to the WHO definition was calculated. Results: The estimated prevalence of osteoporosis was 40.8% of women aged ≥50 years and 17.7% among men. The expected annual incidence was 58,658/million inhabitants in women ≥50 years of age and 23,648/million in men ≥50 years. However, the observed incidence was only 4,823 and 862/million per year, respectively (8.2% and 3.6% of the expected). In 1999, a total of 34,691 hip, spine, and forearm fractures were reported in subjects ≥50 years, and of these, 18,566 were potentially attributable to osteoporosis (14,240 fractures in women and 4,326 in men equaling 14,976 and 5,297/million per year). Only 0.3% of men ≥50 years were receiving a bisphosphonate, while 2.2% of women received a bisphosphonate or raloxifene. Among women ≥50 years, 27.7% received hormone replacement therapy. Conclusions: Osteoporotic fractures of the hip, spine, and forearm are rather frequent in Denmark, but the diagnosis of osteoporosis is rarely used. It seems that osteoporosis is markedly underdiagnosed and undertreated in Denmark as probably also elsewhere. This may have significant implications for the prevention of osteoporotic fractures.

Keywords

Epidemiology Osteoporosis 

References

  1. 1.
    Kannus P, Niemi S, Parkkari J et al (1999) Hip fractures in Finland between 1970 and 1997 and predictions for the future [see comments]. Lancet 353:802–805CrossRefPubMedGoogle Scholar
  2. 2.
    Kannus P, Parkkari J, Sievanen H et al (1996) Epidemiology of hip fractures. Bone 18:57S–63SPubMedGoogle Scholar
  3. 3.
    Alexeeva L, Burkhardt P, Christiansen C et al (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group, 1st edn. WHO Technical Report Series, No. 843. World Health Organization, GenevaGoogle Scholar
  4. 4.
    Faulkner KG, Orwoll E (2002) Implications in the use of T-scores for the diagnosis of osteoporosis in men. J Clin Densitom 5:87–93CrossRefPubMedGoogle Scholar
  5. 5.
    Vestergaard P, Rejnmark L, Mosekilde L (2001) Hip fracture prevention: cost-effective strategies. Pharmacoeconomics 19:449–468PubMedGoogle Scholar
  6. 6.
    Ray NF, Chan JK, Thamer M, Melton LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35PubMedGoogle Scholar
  7. 7.
    Phillips S, Fox N, Jacobs J, Wright WE (1988) The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 9:271–279PubMedGoogle Scholar
  8. 8.
    Frank L (2000) Epidemiology: when an entire country is a cohort. Science 287:2398–2399CrossRefPubMedGoogle Scholar
  9. 9.
    Mosekilde L, Beck-Nielsen H, Sørensen OH et al (2000) Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women—results of the Danish Osteoporosis Prevention Study. Maturitas 36:181–193CrossRefPubMedGoogle Scholar
  10. 10.
    Andersen TF, Madsen M, Jørgensen J, Mellemkjaer L, Olsen JH (1999) The Danish National Hospital Register. Dan Med Bull 46:263–268PubMedGoogle Scholar
  11. 11.
    Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1–10CrossRefPubMedGoogle Scholar
  12. 12.
    Anonymous (1999) Statistical yearbook 1999, 1st edn. Danish Bureau of Statistics, CopenhagenGoogle Scholar
  13. 13.
    Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11:669–674CrossRefPubMedGoogle Scholar
  14. 14.
    Melton LJ III, Crowson CS, O’Fallon WM (1999) Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 9:29–37CrossRefPubMedGoogle Scholar
  15. 15.
    Dawson-Hughes B, Gold DT, Rodbard HW, Bonner FJ JR, Khosla S, Swift S (2003) Physician’s guide to prevention and treatment of osteoporosis, 2nd edn. National Osteoporosis Foundation, Washington DCGoogle Scholar
  16. 16.
    Looker AC, Wahner HW, Dunn WL et al (1999) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–489CrossRefGoogle Scholar
  17. 17.
    Kelly TJ (1990) Bone mineral density reference database for American men and women. J Bone Miner Res 5[Suppl 2]:S249Google Scholar
  18. 18.
    Anonymous (2000) [Changes in the criteria for reimbursement of bisphosphonates or raloxifen for preventing osteoporosis] (in Danish). Ugeskr Laeger 162:6512Google Scholar
  19. 19.
    Rothman KJ (2002) Epidemiology: an introduction, 1st edn. Oxford University Press, OxfordGoogle Scholar
  20. 20.
    Melton LJ III (1995) Epidemiology of fractures. In: Riggs BL, Melton LJ III (eds) Osteoporosis: etiology, diagnosis, and management, 2nd edn. Lippincott-Raven, Philadelphia, pp 225–247Google Scholar
  21. 21.
    Black DM, Cummings SR, Kerpf DB et al (1996) Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541PubMedGoogle Scholar
  22. 22.
    Kanis JA, Johnell O, Oden A et al (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15:20–26CrossRefPubMedGoogle Scholar
  23. 23.
    Ismail AA, Cooper C, Felsenberg D et al (1999) Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int 9:206–213CrossRefPubMedGoogle Scholar
  24. 24.
    Christensen PM, Kristensen IS, Brøsen K, Brixen K, Abrahamsen B, Andersen M (1999) The use of prednisolone and concurrent pharmacological prophylaxis against osteoporosis: a population based study using a drug prescription database. J Bone Miner Res 14[Suppl 1]:S524 (Abstract)Google Scholar
  25. 25.
    Olesen C, Sørensen HT, Steffensen FH, Nielsen GL, Olsen J (1996) Danish data confirm low prevalence of HRT among women prescribed oral corticosteroids. BMJ 313:344–346PubMedGoogle Scholar
  26. 26.
    Køster A (1990) Hormone replacement therapy: use patterns in 51-year-old Danish Women. Maturitas 12:345–356PubMedGoogle Scholar
  27. 27.
    Felsenberg D, Silman AJ, Lunt M et al (2002) Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17:716–724PubMedGoogle Scholar
  28. 28.
    Falch JA (1983) Epidemiology of fractures of the distal forearm in Oslo, Norway. Acta Orthop Scand 54:291–295PubMedGoogle Scholar
  29. 29.
    Kramhøft M, Bødtker S (1988) Epidemiology of distal forearm fractures in Danish children. Acta Orthop Scand 59:557–559PubMedGoogle Scholar
  30. 30.
    Bacon WE, Maggi S, Looker A et al (1996) International comparison of hip fracture rates in 1988–89. Osteoporos Int 6:69–75PubMedGoogle Scholar
  31. 31.
    Brot C, Vestergaard P, Kolthoff N, Gram J, Sørensen OH (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutrition 86[Suppl 1]:97–103Google Scholar
  32. 32.
    Vestergaard P, Mosekilde L (2003) Fracture risk associated with smoking: a meta-analysis. J Intern Med 254:572–583CrossRefPubMedGoogle Scholar
  33. 33.
    Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMedGoogle Scholar
  34. 34.
    Stein E, Shane E (2003) Secondary osteoporosis. Endocrinol Metab Clin North Am 32:115–134PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2004

Authors and Affiliations

  • Peter Vestergaard
    • 1
    • 2
  • Lars Rejnmark
    • 1
  • Leif Mosekilde
    • 1
  1. 1.Department of Endocrinology and Metabolism C, Aarhus University HospitalAarhus AmtssygehusAarhusDenmark
  2. 2.The Osteoporosis ClinicAarhus AmtssygehusAarhus CDenmark

Personalised recommendations